Pacific Biosciences

Sequence with confidence

Employees
501–1000
Founded
2004
Business Model
B2B
Total Funding
$900.0M
Last Round
$900.0M Convertible NoteFeb 2021
Rounds
1

About

Pacific Biosciences (PacBio) develops long-read DNA sequencing systems enabling complete and accurate genome, transcriptome, and epigenome analysis. Its HiFi sequencing technology combines the completeness of long reads with short-read accuracy. Founded in 2004 and headquartered in Menlo Park, California, PacBio serves research, clinical, biopharma, and public health markets globally.

Summary

Pacific Biosciences is a Biotech company based in Menlo Park, United States, founded in 2004. It has raised $900.0M in total across 1 round, most recently a $900.0M Convertible Note round in Feb 2021. Investors include SoftBank.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

ConvertibleConvertible NoteFeb 2021
$900.0M

Investors

Similar Companies